Global Tuberculosis Diagnostic Market Insights and Forecast to 2028

Table Of Contents

1 Report Business Overview

1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Radiographic Method 1.2.3 Diagnostic Laboratory Methods 1.2.4 Nucleic Acid Testing 1.2.5 Phage Assay 1.2.6 Detection of Latent Infection 1.2.7 Cytokine Detection Assay 1.2.8 Detection of Drug Resistance 1.3 Market by Application 1.3.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Infants 1.3.3 Adults 1.4 Study Objectives 1.5 Years Considered2 Global Growth Trends 2.1 Global Tuberculosis Diagnostic Market Perspective (2017-2028) 2.2 Tuberculosis Diagnostic Growth Trends by Region 2.2.1 Tuberculosis Diagnostic Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Tuberculosis Diagnostic Historic Market Size by Region (2017-2022) 2.2.3 Tuberculosis Diagnostic Forecasted Market Size by Region (2023-2028) 2.3 Tuberculosis Diagnostic Market Dynamics 2.3.1 Tuberculosis Diagnostic Industry Trends 2.3.2 Tuberculosis Diagnostic Market Drivers 2.3.3 Tuberculosis Diagnostic Market Challenges 2.3.4 Tuberculosis Diagnostic Market Restraints3 Competition Landscape by Key Players 3.1 Global Top Tuberculosis Diagnostic Players by Revenue 3.1.1 Global Top Tuberculosis Diagnostic Players by Revenue (2017-2022) 3.1.2 Global Tuberculosis Diagnostic Revenue Market Share by Players (2017-2022) 3.2 Global Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Tuberculosis Diagnostic Revenue 3.4 Global Tuberculosis Diagnostic Market Concentration Ratio 3.4.1 Global Tuberculosis Diagnostic Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostic Revenue in 2021 3.5 Tuberculosis Diagnostic Key Players Head office and Area Served 3.6 Key Players Tuberculosis Diagnostic Product Solution and Service 3.7 Date of Enter into Tuberculosis Diagnostic Market 3.8 Mergers & Acquisitions, Expansion Plans4 Tuberculosis Diagnostic Breakdown Data by Type 4.1 Global Tuberculosis Diagnostic Historic Market Size by Type (2017-2022) 4.2 Global Tuberculosis Diagnostic Forecasted Market Size by Type (2023-2028)5 Tuberculosis Diagnostic Breakdown Data by Application 5.1 Global Tuberculosis Diagnostic Historic Market Size by Application (2017-2022) 5.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2023-2028)6 North America 6.1 North America Tuberculosis Diagnostic Market Size (2017-2028) 6.2 North America Tuberculosis Diagnostic Market Size by Type 6.2.1 North America Tuberculosis Diagnostic Market Size by Type (2017-2022) 6.2.2 North America Tuberculosis Diagnostic Market Size by Type (2023-2028) 6.2.3 North America Tuberculosis Diagnostic Market Share by Type (2017-2028) 6.3 North America Tuberculosis Diagnostic Market Size by Application 6.3.1 North America Tuberculosis Diagnostic Market Size by Application (2017-2022) 6.3.2 North America Tuberculosis Diagnostic Market Size by Application (2023-2028) 6.3.3 North America Tuberculosis Diagnostic Market Share by Application (2017-2028) 6.4 North America Tuberculosis Diagnostic Market Size by Country 6.4.1 North America Tuberculosis Diagnostic Market Size by Country (2017-2022) 6.4.2 North America Tuberculosis Diagnostic Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada7 Europe 7.1 Europe Tuberculosis Diagnostic Market Size (2017-2028) 7.2 Europe Tuberculosis Diagnostic Market Size by Type 7.2.1 Europe Tuberculosis Diagnostic Market Size by Type (2017-2022) 7.2.2 Europe Tuberculosis Diagnostic Market Size by Type (2023-2028) 7.2.3 Europe Tuberculosis Diagnostic Market Share by Type (2017-2028) 7.3 Europe Tuberculosis Diagnostic Market Size by Application 7.3.1 Europe Tuberculosis Diagnostic Market Size by Application (2017-2022) 7.3.2 Europe Tuberculosis Diagnostic Market Size by Application (2023-2028) 7.3.3 Europe Tuberculosis Diagnostic Market Share by Application (2017-2028) 7.4 Europe Tuberculosis Diagnostic Market Size by Country 7.4.1 Europe Tuberculosis Diagnostic Market Size by Country (2017-2022) 7.4.2 Europe Tuberculosis Diagnostic Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries8 Asia-Pacific 8.1 Asia-Pacific Tuberculosis Diagnostic Market Size (2017-2028) 8.2 Asia-Pacific Tuberculosis Diagnostic Market Size by Type 8.2.1 Asia-Pacific Tuberculosis Diagnostic Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Tuberculosis Diagnostic Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Tuberculosis Diagnostic Market Share by Type (2017-2028) 8.3 Asia-Pacific Tuberculosis Diagnostic Market Size by Application 8.3.1 Asia-Pacific Tuberculosis Diagnostic Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Tuberculosis Diagnostic Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Tuberculosis Diagnostic Market Share by Application (2017-2028) 8.4 Asia-Pacific Tuberculosis Diagnostic Market Size by Region 8.4.1 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Tuberculosis Diagnostic Market Size (2017-2028) 9.2 Latin America Tuberculosis Diagnostic Market Size by Type 9.2.1 Latin America Tuberculosis Diagnostic Market Size by Type (2017-2022) 9.2.2 Latin America Tuberculosis Diagnostic Market Size by Type (2023-2028) 9.2.3 Latin America Tuberculosis Diagnostic Market Share by Type (2017-2028) 9.3 Latin America Tuberculosis Diagnostic Market Size by Application 9.3.1 Latin America Tuberculosis Diagnostic Market Size by Application (2017-2022) 9.3.2 Latin America Tuberculosis Diagnostic Market Size by Application (2023-2028) 9.3.3 Latin America Tuberculosis Diagnostic Market Share by Application (2017-2028) 9.4 Latin America Tuberculosis Diagnostic Market Size by Country 9.4.1 Latin America Tuberculosis Diagnostic Market Size by Country (2017-2022) 9.4.2 Latin America Tuberculosis Diagnostic Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil10 Middle East & Africa 10.1 Middle East & Africa Tuberculosis Diagnostic Market Size (2017-2028) 10.2 Middle East & Africa Tuberculosis Diagnostic Market Size by Type 10.2.1 Middle East & Africa Tuberculosis Diagnostic Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Tuberculosis Diagnostic Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Tuberculosis Diagnostic Market Share by Type (2017-2028) 10.3 Middle East & Africa Tuberculosis Diagnostic Market Size by Application 10.3.1 Middle East & Africa Tuberculosis Diagnostic Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Tuberculosis Diagnostic Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Tuberculosis Diagnostic Market Share by Application (2017-2028) 10.4 Middle East & Africa Tuberculosis Diagnostic Market Size by Country 10.4.1 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE11 Key Players Profiles 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Details 11.1.2 Thermo Fisher Scientific Business Overview 11.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Introduction 11.1.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2017-2022) 11.1.5 Thermo Fisher Scientific Recent Developments 11.2 Hologic Corporation 11.2.1 Hologic Corporation Company Details 11.2.2 Hologic Corporation Business Overview 11.2.3 Hologic Corporation Tuberculosis Diagnostic Introduction 11.2.4 Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2017-2022) 11.2.5 Hologic Corporation Recent Developments 11.3 Abbott 11.3.1 Abbott Company Details 11.3.2 Abbott Business Overview 11.3.3 Abbott Tuberculosis Diagnostic Introduction 11.3.4 Abbott Revenue in Tuberculosis Diagnostic Business (2017-2022) 11.3.5 Abbott Recent Developments 11.4 Becton Dickinson 11.4.1 Becton Dickinson Company Details 11.4.2 Becton Dickinson Business Overview 11.4.3 Becton Dickinson Tuberculosis Diagnostic Introduction 11.4.4 Becton Dickinson Revenue in Tuberculosis Diagnostic Business (2017-2022) 11.4.5 Becton Dickinson Recent Developments 11.5 Roche 11.5.1 Roche Company Details 11.5.2 Roche Business Overview 11.5.3 Roche Tuberculosis Diagnostic Introduction 11.5.4 Roche Revenue in Tuberculosis Diagnostic Business (2017-2022) 11.5.5 Roche Recent Developments 11.6 bioMerieux 11.6.1 bioMerieux Company Details 11.6.2 bioMerieux Business Overview 11.6.3 bioMerieux Tuberculosis Diagnostic Introduction 11.6.4 bioMerieux Revenue in Tuberculosis Diagnostic Business (2017-2022) 11.6.5 bioMerieux Recent Developments 11.7 Sanofi 11.7.1 Sanofi Company Details 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Tuberculosis Diagnostic Introduction 11.7.4 Sanofi Revenue in Tuberculosis Diagnostic Business (2017-2022) 11.7.5 Sanofi Recent Developments 11.8 Cepheid 11.8.1 Cepheid Company Details 11.8.2 Cepheid Business Overview 11.8.3 Cepheid Tuberculosis Diagnostic Introduction 11.8.4 Cepheid Revenue in Tuberculosis Diagnostic Business (2017-2022) 11.8.5 Cepheid Recent Developments 11.9 Hain Lifescience 11.9.1 Hain Lifescience Company Details 11.9.2 Hain Lifescience Business Overview 11.9.3 Hain Lifescience Tuberculosis Diagnostic Introduction 11.9.4 Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2017-2022) 11.9.5 Hain Lifescience Recent Developments 11.10 QIAGEN 11.10.1 QIAGEN Company Details 11.10.2 QIAGEN Business Overview 11.10.3 QIAGEN Tuberculosis Diagnostic Introduction 11.10.4 QIAGEN Revenue in Tuberculosis Diagnostic Business (2017-2022) 11.10.5 QIAGEN Recent Developments12 Analyst's Viewpoints/Conclusions13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer